After five years behind bars for insider trading, Waksal has announced another biotech deal: His new drug company Kadmon Pharmaceuticals has bought privately held Three Rivers Pharmaceuticals in a private deal estimated at over…
Tiny, little-known biotech Clinical Data has developed a potential blockbuster drug called Vilazodone. If OK’d, it would be the first new depression treatment in 15 years. Its potential is so huge that several Big Pharmas are s…
Shares of pharmaceutical companies Amylin, Alkermes, and Eli Lilly — partners in a new diabetes drug Bydureon — have tanked in morning trading as the U.S. Food and Drug Administration declined on Tuesday to approve the drug w…
It’s an important question because 5,000 potential lawsuits alleging that vaccines caused autism lurk in the background, and vaccine makers threaten to stop producing the drugs if the suits are allowed.
Continu…
Global pharmaceutical sales are expected to grow by 5% to 7% in 2011, thanks to robust growth in emerging markets, especially China, as well as new innovative treatments, and despite patent expirations and budget pressures in t…